MeSH Browser

MeSH Heading: Amphotericin B
Tree Number(s): D02.540.576.500.500
Unique ID: D000666
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000666
Scope Note: Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Entry Term(s): Amphocil; Amphotericin; Amphotericin B Cholesterol Dispersion; Amphotericin B Colloidal Dispersion; Fungizone
Pharm Action: Amebicides
Anti-Bacterial Agents
Antifungal Agents
Antiprotozoal Agents
Related Numbers: 1397-89-3
CAS Type 1 Name: 14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-
Public MeSH Note: 98; AMPHOCIL (now AMPHOTERICIN B) was indexed under AMPHOTERICIN B/*analogs & derivatives & CHOLESTEROL ESTERS 1992-97
History Note: 98; for AMPHOCIL use AMPHOTERICIN B (NM) 1992-97
Date Established: 1998/01/01
Date of Entry: 1999/01/01
Revision Date: 2017/12/08

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Amphotericin B MeSH Descriptor Data 2024